---
figid: PMC7550684__fnagi-12-566922-g0001
figlink: pmc/articles/PMC7550684/figure/F1/
number: F1
caption: Signaling pathway of Interleukin-17A (IL-17A). The heterodimer receptor consists
  of two subunits, IL-17RA and IL-17RF, which bind to IL-17A, IL-17F, and IL-17AF
  ligands. The intracellular SEF/IL-17 receptor (SEFIR) domains interact with a corresponding
  SEFIR motif on the Act1 adaptor (Novatchkova et al., ). TNF-receptor associated
  factor 6 (TRAF6) and TRAF2/5 proteins bind to the TRAF-binding site in Act1. After
  binding to Act1, TRAF6 mediates the activation of the classical nuclear factor-κB
  (NF-KB) pathway of MAPK:AP-1. Collectively, these pathways trigger the transcriptional
  induction of target genes (Qian et al., ). In the IL-17 signaling pathway, a pathway
  of post-transcriptional mRNA stabilization is promoted through the recruitment of
  TRAF2 and TRAF5 by Act1 (Schwandner et al., ). This physiological process is achieved
  by controlling multiple RNA-binding proteins, such as HuR and Arid5a.
pmcid: PMC7550684
papertitle: 'Interleukin-17A: The Key Cytokine in Neurodegenerative Diseases.'
reftext: Junjue Chen, et al. Front Aging Neurosci. 2020;12:566922.
pmc_ranked_result_index: '31972'
pathway_score: 0.9579151
filename: fnagi-12-566922-g0001.jpg
figtitle: Signaling pathway of Interleukin-17A (IL-17A)
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7550684__fnagi-12-566922-g0001.html
  '@type': Dataset
  description: Signaling pathway of Interleukin-17A (IL-17A). The heterodimer receptor
    consists of two subunits, IL-17RA and IL-17RF, which bind to IL-17A, IL-17F, and
    IL-17AF ligands. The intracellular SEF/IL-17 receptor (SEFIR) domains interact
    with a corresponding SEFIR motif on the Act1 adaptor (Novatchkova et al., ). TNF-receptor
    associated factor 6 (TRAF6) and TRAF2/5 proteins bind to the TRAF-binding site
    in Act1. After binding to Act1, TRAF6 mediates the activation of the classical
    nuclear factor-κB (NF-KB) pathway of MAPK:AP-1. Collectively, these pathways trigger
    the transcriptional induction of target genes (Qian et al., ). In the IL-17 signaling
    pathway, a pathway of post-transcriptional mRNA stabilization is promoted through
    the recruitment of TRAF2 and TRAF5 by Act1 (Schwandner et al., ). This physiological
    process is achieved by controlling multiple RNA-binding proteins, such as HuR
    and Arid5a.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL17RA
  - TRAF3IP2
  - IL17A
  - TRAF2
  - TRAF5
  - ELAVL1
  - ARID5A
  - TRAF6
  - MAPK14
  - MAPK3
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK1
  - MAPK9
  - MAPK10
  - MAK
  - NR2C2
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - FOS
  - FOSB
  - FOSL2
  - JUN
  - JUNB
  - FOSL1
  - JUND
genes:
- word: IL-17RA
  symbol: IL-17RA
  source: hgnc_alias_symbol
  hgnc_symbol: IL17RA
  entrez: '23765'
- word: АСТ1
  symbol: ACT1
  source: hgnc_alias_symbol
  hgnc_symbol: TRAF3IP2
  entrez: '10758'
- word: IL-17A
  symbol: IL-17A
  source: hgnc_alias_symbol
  hgnc_symbol: IL17A
  entrez: '3605'
- word: TRAF2/5
  symbol: TRAF2
  source: hgnc_symbol
  hgnc_symbol: TRAF2
  entrez: '7186'
- word: TRAF2/5
  symbol: TRAF5
  source: hgnc_symbol
  hgnc_symbol: TRAF5
  entrez: '7188'
- word: HUR
  symbol: HUR
  source: hgnc_prev_symbol
  hgnc_symbol: ELAVL1
  entrez: '1994'
- word: Arid5a
  symbol: ARID5A
  source: hgnc_symbol
  hgnc_symbol: ARID5A
  entrez: '10865'
- word: ACT1
  symbol: ACT1
  source: hgnc_alias_symbol
  hgnc_symbol: TRAF3IP2
  entrez: '10758'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: МАРК
  symbol: MAK
  source: hgnc_symbol
  hgnc_symbol: MAK
  entrez: '4117'
- word: TAK1
  symbol: TAK1
  source: hgnc_alias_symbol
  hgnc_symbol: NR2C2
  entrez: '7182'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
chemicals: []
diseases: []
figid_alias: PMC7550684__F1
redirect_from: /figures/PMC7550684__F1
figtype: Figure
---
